Summary of animal models of myelodysplastic syndrome
Abstract Myelodysplastic syndrome (MDS) is a malignant tumor of the hematological system characterized by long‐term, progressive refractory hemocytopenia. In addition, the risk of leukemia is high, and once it develops, the course of acute leukemia is short with poor curative effect. Animal models a...
Main Authors: | Weisha Li, Mengyuan Li, Xingjiu Yang, Wenlong Zhang, Lin Cao, Ran Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Animal Models and Experimental Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ame2.12144 |
Similar Items
-
Novel spontaneous myelodysplastic syndrome mouse model
by: Weisha Li, et al.
Published: (2021-06-01) -
Autoimmune syndromes presenting as a paraneoplastic manifestation of myelodysplastic syndromes: clinical features, course, treatment and outcome
by: Bradley T. Williamson, et al.
Published: (2016-05-01) -
The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01) -
Management of Adult Patients with Myelodysplastic Syndromes
by: Nicolas Bonadies
Published: (2017-08-01) -
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01)